Peter Joyce

CEO and Founder @Greywolf Therapeutics

Oxford, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2018 — Present

CEO and Founder @Greywolf Therapeutics

View department →

Oxford, GB

EDUCATION

2004 — 2008

University of Bristol

PhD, Biochemistry and Genetics

2001 — 2004

University of Bristol

BSc, Biochemistry - 1st class honours degree

SKILLS

Molecular CloningAnimal ModelsBiochemistryDrug DiscoveryTranslational MedicineNeuroscienceWestern BlottingMolecular GeneticsNeurodegenerationProtein PurificationDna ElectrophoresisDisease ModelsMammalian Cell CultureImmunoprecipitationDrug DevelopmentRna BiologyRnaiTumor ImmunologyPharmaceutical IndustryDna SequencingImmunohistochemistryMolecular BiologyBacterial Cell CultureRare DiseasesMouse ModelsMouse BehaviourManagementPcrImmunofluorescencePrimary Cell IsolationMicroscopyProject ManagementTeam LeadershipLife SciencesDna ExtractionReal-Time PcrCell Biology

ABOUT PETER JOYCE

Drug discovery professional with broad experience from both industrial and academic contexts. Extensive knowledge across oncology, neurodegeneration, and rare diseases.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Peter Joyce — CEO and Founder at Greywolf Therapeutics in Oxford, GB | Unifers